|Mr. David Eric Klein||CEO & Director||2.23M||N/A||1964|
|Mr. Rade Nikola Kovacevic||Pres & Chief Product Officer||642.6k||4.11M||1986|
|Mr. Michael Alan Lee||Exec. VP & CFO||824.95k||N/A||1973|
|Mr. Thomas Carlton Stewart||VP & Chief Accounting Officer||344.36k||N/A||1982|
|Mr. Phillip Stephen Shaer||Chief Legal Officer||267.83k||N/A||1974|
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis for recreational and medical purposes primarily in Canada, the United States, Germany, and the United Kingdom. It operates through two segments, Cannabis, Hemp and Other Consumer Products; and Canopy Rivers. The company's products include dried cannabis flowers, oils and concentrates, and softgel capsules. It offers its products under the Tweed, Quatreau, Deep Space, Spectrum Therapeutics, First & Free, TWD, This Works, BioSteel, DNA Genetics CraftGrow, Tokyo Smoke, DOJA, Van der Pop, and Bean & Bud brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada and NHL Alumni Association to examine the efficacy of CBD-based therapies as part of the mitigation of persistent post-concussion symptoms. As of February 14, 2020, it operated 28 cannabis retail stores under the Tweed or Tokyo Smoke name. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
Canopy Growth Corporation’s ISS Governance QualityScore as of December 8, 2019 is 10. The pillar scores are Audit: 10; Board: 7; Shareholder Rights: 6; Compensation: 9.